The Scientific and Research Team at Arbutus Biopharma is responsible for driving the discovery and development of innovative therapies aimed at curing chronic hepatitis B infection. Comprising experts in medicinal chemistry, biology, immunology, and pharmacology, the team conducts cutting-edge research, develops new compounds, and translates scientific discoveries into clinical applications, ensuring rigorous analytical and preclinical testing to advance therapeutic candidates toward commercialization.
View all